Stockreport

Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors

Prelude Therapeutics Incorporated  (PRLD) 
PDF WILMINGTON, Del., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the [Read more]